Your browser doesn't support javascript.
loading
Anti-inflammatory therapy for cardiovascular disease.
Kosmas, Constantine E; Silverio, Delia; Sourlas, Andreas; Montan, Peter D; Guzman, Eliscer; Garcia, Mario J.
Afiliación
  • Kosmas CE; Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.
  • Silverio D; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA.
  • Sourlas A; School of Medicine, University of Crete, Heraklion, Greece.
  • Montan PD; Cardiology Clinic, Cardiology Unlimited, PC, New York, NY, USA.
  • Guzman E; Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.
  • Garcia MJ; Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Ann Transl Med ; 7(7): 147, 2019 Apr.
Article en En | MEDLINE | ID: mdl-31157268
Chronic subclinical inflammation is a central process in the pathogenesis of cardiovascular disease (CVD) and it has been linked with both the initiation and progression of atherosclerosis. Several pro-inflammatory cytokines, such as the C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) have been described as independent risk factors for coronary heart disease and promoters of atherogenesis. Thus, extensive research is being conducted to assess the role of anti-inflammatory therapy in the primary and secondary prevention of CVD. Our review aims to provide the clinical and scientific data pertaining to the effects of different anti-inflammatory agents administered in patients with CVD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Ann Transl Med Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Ann Transl Med Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: China